| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6000530 | Thrombosis Research | 2016 | 7 Pages |
Abstract
The results of this markedly underpowered trial, albeit suggestive of a potential maternal benefit, cannot support high-dose AT supplementation to improve fetal/neonatal outcomes in early preeclampsia.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Armando D'Angelo, Luca Valsecchi, On behalf of the ATIII-Early Preeclampsia Study Group (ATIII-EPAS) On behalf of the ATIII-Early Preeclampsia Study Group (ATIII-EPAS),